Col17a1-protective peptides for hair follicle stem-cell niche longevity

Overview

Enloq Foundry has developed pioneering peptides aimed at safeguarding the hair follicle stem-cell niche. These peptides target COL17A1, a crucial hemidesmosomal anchor, by selectively inhibiting the protease ELANE, which is responsible for its degradation. By preventing the cleavage of COL17A1, these peptides help to maintain the integrity of the stem-cell environment, thereby slowing down the aging process of hair follicles. This innovation leverages advanced AI-driven design techniques to create peptides that are both selective and stable, offering significant potential in hair vitality therapies.

Technical specifications

• Target Mechanism: Inhibition of ELANE protease to protect COL17A1, preventing stem-cell loss in hair follicles.
• Design Process: Utilizes AI-driven multi-agent design loops to optimize elastase binding and selectivity.
• Validation Stages: Includes in-vitro and ex-vivo testing for efficacy and safety, focusing on elastase inhibition, COL17A1 integrity, and hair follicle health.
• Formulation: Developed for optimal penetration and delivery to the hair follicle bulge, with stability and safety confirmed for pilot trials.

Technology readiness level

The technology is currently at TRL 3, indicating successful proof of concept in a laboratory setting with ongoing validation efforts to prepare for pilot trials.